Trial intelligence / Profile preview

Comparison of Two Sensor-Augmented Glycemic Control Systems in T1DM

NCT00797823Phase 2Completed

Sponsor
Legacy Health
Start
Nov 2008
Primary completion
Sep 2009
Modality
Peptides, Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of glucagon in type 1 diabetes mellitus (T1D), sponsored by Legacy Health. Started Nov 2008; status: completed.

02

Drugs

glucagon
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT00797823.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00797823.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call